Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 7, 2011, Pages 610-621

  Lahiani Cohen, Inbal ^a   Lourbopoulos, Athanasios ^b   Haber, Ester ^a   Rozenstein Tsalkovich, Lea ^a   Abramsky, Oded ^a   Grigoriadis, Nikolaos ^b   Rosenmann, Hanna ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Alzheimer disease; Brain derived neurotrophic factor; Environmental enrichment; Neurofibrillary tangles; Neurogenesis; Tau; Tauopathy

Indexed keywords

AMYLOID; BRAIN DERIVED NEUROTROPHIC FACTOR; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; COGNITION; DEMENTIA; ENVIRONMENTAL ENRICHMENT; IMMUNOREACTIVITY; MAZE TEST; MICROGLIA; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; TAUOPATHY; TRANSGENIC MOUSE;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MUTATION; NEUROFIBRILLARY TANGLES; NEUROGENESIS; SPACE PERCEPTION; STATISTICS, NONPARAMETRIC; TAU PROTEINS; TAUOPATHIES;

EID: 79959529114     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318221bfab     Document Type: Article

References (74)

1. Friedland RP, Fritsch T, Smyth KA, et al. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci U S A 2001;98:3440-45 (Pubitemid 32220864)
2. Scarmeas N, Levy G, Tang MX, et al. Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 2001;57:2236-42 (Pubitemid 34016457)
3. Stern Y, Gurland B, Tatemichi TK, et al. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994; 271:1004-10 (Pubitemid 24099921)
4. Letenneur L, Gilleron V, Commenges D, et al. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 1999;66:177-83 (Pubitemid 29103518)
5. Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003;348:2508-16 (Pubitemid 36706538)
6. Wilson RS, Bennett DA, Bienias JL, et al. Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002; 59:1910-14 (Pubitemid 36076563)
7. Lautenschlager NT, Cox KL, Flicker L, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA 2008;300:1027-37
8. Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive reserve: Mental and physical activity as modulators of brain disorders. Prog Neurobiol 2009;89:369-82
9. Choi SH, Veeraraghavalu K, Lazarov O, et al. Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 2008;59:568-80
10. Ehninger D, Kempermann G. Regional effects of wheel running and environmental enrichment on cell genesis and microglia proliferation in the adult murine neocortex. Cereb Cortex 2003;13:845-51 (Pubitemid 36917964)
11. Villeda S, Wyss-Coray T. Microglia - a wrench in the running wheel? Neuron 2008;59:527-29
12. Ziv Y, Ron N, Butovsky O, et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 2006;9:268-75 (Pubitemid 43164551)
13. Berardi N, Braschi C, Capsoni S, et al. Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration. J Alzheimers Dis 2007;11:359-70 (Pubitemid 47094033)
14. Cracchiolo JR, Mori T, Nazian SJ, et al. Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce AA deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 2007;88:277-94 (Pubitemid 47321221)
15. Lazarov O, Robinson J, Tang YP, et al. Environmental enrichment reduces AA levels and amyloid deposition in transgenic mice. Cell 2005; 120:701-13 (Pubitemid 40343081)
16. Pardon MC, Sarmad S, Rattray I, et al. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocanna-binoids levels. Neurobiol Aging 2009;30:1099-113
17. Costa DA, Cracchiolo JR, Bachstetter AD, et al. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging 2007;28:831-44 (Pubitemid 46613825)
18. Arendash G, Garcia MF, Costa DA, et al. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable A-amyloid deposition. Neuroreport 2004;15:1751-54 (Pubitemid 39062588)
19. Jankowsky JL, Melnikova T, Fadale DJ, et al. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 2005;25:5217-24 (Pubitemid 40726973)
20. Jankowsky JL, Xu G, Fromholt D, et al. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2003;62:1220-27 (Pubitemid 37494191)
21. Levi O, Jongen-Relo AL, Feldon J, et al. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis 2003;13:273-82 (Pubitemid 36937209)
22. Levi O, Michaelson DM. Environmental enrichment stimulates neuro-genesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J Neurochem 2007;100:202-10 (Pubitemid 46085849)
23. Arriagada PV, Growdon JH, Hedley-Whyte ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
24. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995; 52:81-88
25. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
26. Fisher A, Heldman E, Gurwitz D, et al. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update. Ann N Y Acad Sci 1996;777:189-96
27. Nuydens R, Dispersyn G, de Jong M, et al. Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells. Biochem Biophys Res Commun 1997;240:687-91 (Pubitemid 28271779)
28. Shelton SB, Johnson GV. Tau and HMW tau phosphorylation and com-partmentalization in apoptotic neuronal PC12 cells. J Neurosci Res 2001; 66:203-13 (Pubitemid 32912289)
29. Hu YS, Xu P, Pigino G, et al. Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neu-ropathology in familial Alzheimer's disease-linked APPswe/PS1{Delta}E9 mice. FASEB J 2010;24:1667-81
30. Small SA, Duff K. Linking AA and tau in late-onset Alzheimer's disease: A dual pathway hypothesis. Neuron 2008;60:534-42
31. Rosenmann H, Grigoriadis N, Eldar-Levy H, et al. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Exp Neurol 2008;212:71-84
32. Elliott E, Atlas R, Lange A, et al. Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 kinase signalling mechanism. Eur J Neurosci 2005;22:1081-89 (Pubitemid 41395371)
33. Leem YH, Lim HJ, Shim SB, et al. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies. J Neurosci Res 2009;87:2561-70
34. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8
35. Boimel M, Grigoriadis N, Lourbopoulos A, et al. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Exp Neurol 2010;224:472-85
36. Rosenmann H, Grigoriadis N, Karussis D, et al. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 2006;63:1459-67 (Pubitemid 44547559)
37. Shiryaev N, Jouroukhin Y, Giladi E, et al. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauo-pathy model. Neurobiol Dis 2009;34:381-88
38. Wilms H, Hartmann D, Sievers J. Ramification of microglia, monocytes and macrophages in vitro: Influences of various epithelial and mes-enchymal cells and their conditioned media. Cell Tissue Res 1997; 287:447-58 (Pubitemid 27113126)
39. Eder C, Schilling T, Heinemann U, et al. Morphological, immunophe-notypical and electrophysiological properties of resting microglia in vitro. Eur J Neurosci 1999;11:4251-61 (Pubitemid 30009256)
40. King TW, Brey EM, Youssef AA, et al. Quantification of vascular density using a semiautomated technique for immunostained specimens. Anal Quant Cytol Histol 2002;24:39-48 (Pubitemid 34160967)
41. Goto M, Nagatomo Y, Hasui K, et al. Chromaticity analysis of immu-nostained tumor specimens. Pathol Res Pract 1992;188:433-37
42. Kuyatt BL, Reidy CA, Hui KY, et al. Quantitation of smooth muscle proliferation in cultured aorta. A color image analysis method for the Macintosh. Anal Quant Cytol Histol 1993;15:83-87 (Pubitemid 23158930)
43. Zueger M, Urani A, Chourbaji S, et al. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett 2005; 374:142-46 (Pubitemid 40092213)
44. Olton D. Rememberance of places passed: Spatial memory in rats. J Exp Psychol Anim Behav Processes 1976;2:179-216
45. Yanai J, Pick CG. Studies on noradrenergic alterations in relation to early phenobarbital-induced behavioral changes. Int J Dev Neurosci 1987; 5:337-44 (Pubitemid 18082327)
46. Avraham Y, Bonne O, Berry EM. Behavioral and neurochemical alterations caused by diet restriction - the effect of tyrosine administration in mice. Brain Res 1996;732:133-44 (Pubitemid 26305298)
47. Dagon Y, Avraham Y, Link G, et al. The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochro-mocytoma PC12 cells. Neurobiol Dis 2007;27:174-81 (Pubitemid 47088978)
48. Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neu-rosci 2006;7:697-709 (Pubitemid 44267494)
49. O'Callaghan RM, Griffin EW, Kelly AM. Long-term treadmill exposure protects against age-related neurodegenerative change in the rat hippocampus. Hippocampus 2009;19:1019-29
50. Kempermann G, Wiskott L, Gage FH. Functional significance of adult neurogenesis. Curr Opin Neurobiol 2004;14:186-91 (Pubitemid 38479935)
51. Van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci 2000;1:191-98
52. Brown J, Cooper-Kuhn CM, Kempermann G, et al. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 2003;17:2042-46 (Pubitemid 36713965)
53. Herring A, Ambree O, Tomm M, et al. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol 2009;216:184-92
54. Mirochnic S, Wolf S, Staufenbiel M, et al. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 2009;19:1008-18
55. Allen B, Ingram E, Takao M, et al. Abundant tau filaments and non-apoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002;22:9340-51 (Pubitemid 35356177)
56. Dawson HN, Cantillana V, Chen L, et al. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinson-ism linked to chromosome 17 tauopathy in a mouse model. J Neurosci 2007;27:9155-68 (Pubitemid 47312069)
57. Lewis J, McGowan E, Rockwood J, et al. Neurofibrillary tangles, amyo-trophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000;25:402-5 (Pubitemid 32983430)
58. Terwel D, Lasrado R, Snauwaert J, et al. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 2005;280:3963-73 (Pubitemid 40227485)
59. Shim SB, Lim HJ, Chae KR, et al. Tau overexpression in transgenic mice induces glycogen synthase kinase 3A and A-catenin phosphorylation. Neuroscience 2007;146:730-40 (Pubitemid 46617052)
60. Colton CA, Wilcock DM. Assessing activation states in microglia. CNS Neurol Disord Drug Targets 2010;9:174-91
61. Tynan RJ, Naicker S, Hinwood M, et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun 2010;24:1058-68
62. Perry VH. Contribution of systemic inflammation to chronic neurode-generation. Acta Neuropathol 2010;120:277-86
63. Boimel M, Grigoriadis N, Lourbopoulos A, et al. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuro-pathol Exp Neurol 2009;68:314-25
64. Ishizawa K, Dickson DW. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 2001;60:647-57 (Pubitemid 32523629)
65. Yoshiyama Y, Higuchi M, Zhang B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007;53:337-51 (Pubitemid 46161268)
66. Angelucci F, De Bartolo P, Gelfo F, et al. Increased concentrations of nerve growth factor and brain-derived neurotrophic factor in the rat cerebellum after exposure to environmental enrichment. Cerebellum 2009;8:499-506
67. Cotman CW, Berchtold NC. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002;25:295-301 (Pubitemid 34667010)
68. Falkenberg T, Mohammed AK, Henriksson B, et al. Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neu-rosci Lett 1992;138:153-56
69. Chen MJ, Russo-Neustadt AA. Exercise activates the phosphatidylino-sitol 3-kinase pathway. Brain Res Mol Brain Res 2005;135:181-93 (Pubitemid 40602410)
70. Mai L, Jope RS, Li X. BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents. J Neurochem 2002;82:75-83 (Pubitemid 34755251)
71. Park SW, Lee JG, Ha EK, et al. Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. Eur Neuropsychopharmacol 2009;19:356-62
72. Lee JG, Cho HY, Park SW, et al. Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1001-6
73. Ortega F, Perez-Sen R, Morente V, et al. P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neurons. Cell Mol Life Sci 2010; 67:1723-33
74. Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, et al. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 2010;49:10039-41